osimertinib (tagrisso) Report issue

Small molecule Orphan Drug FDA Approved FDA Fast Track FDA Accelerated Approval FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA MeSH PubChem repoDB
Back

Drug Pricing Summary

AUS PBS

$203.2356

VA Big4

$367.1307 - $367.2843

VA FSS

$481.2827

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
osimertinib 40 (TABLET) $367.2843 VA Big4
  • TAGRISSO (30)
    		•  ASTRAZENECA PHARMACEUTICALS LP
    osimertinib 40 (TABLET) $481.2827 VA FSS
  • TAGRISSO (30)
    		•  ASTRAZENECA PHARMACEUTICALS LP
    osimertinib 40 mg (TABLET) $203.2356 AUS PBS generic
  • Tagrisso (30)
    		•  AstraZeneca Pty Ltd
    osimertinib 80 (TABLET) $367.1307 VA Big4
  • TAGRISSO (30)
    		•  ASTRAZENECA PHARMACEUTICALS LP
    osimertinib 80 (TABLET) $481.2827 VA FSS
  • TAGRISSO (30)
    		•  ASTRAZENECA PHARMACEUTICALS LP
    osimertinib 80 mg (TABLET) $203.2356 AUS PBS generic
  • Tagrisso (30)
    		•  AstraZeneca Pty Ltd

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue